RSS .92| RSS 2.0| ATOM 0.3
  • Home
  •  

    Knee Pain: The Verdict Is In On Glucosamine Vs Prescription Pain Killers

    Knee pain sufferers who weren’t sure if they should take the
    supplement glucosamine or pain killers for knee pain relief
    now have some answers to this frequently debated question.

    Two clinical trials have found that knee pain sufferers got
    more pain relief with glucosamine than with a commonly used
    painkiller in Europe.

    Glucosamine is already widely used for knee pain and other
    arthritis related ailments in the United States. US
    consumers spent $800 million on glucosamine during 2004, and
    in Japan retail sales reached $200 million, according to
    Euromonitor.

    Glucosamine is often used in combination with chondroitin
    sulphate.

    One trial by the US government-funded National Institutes of
    Health involved almost 1,500 osteoarthritis patients. They
    were given a daily dose of either 1,500 mg of glucosamine
    hydrochloride, 1,200 mg of chondroitin sulphate, a
    combination of both supplements, 200 mg of the common
    prescription painkiller celecoxib (Celebrex) or a placebo
    for 24 weeks.

    The patients were evaluated at baseline and every four weeks
    thereafter.

    The authors of the study said celecoxib and the glucosamine-
    chondroitin combination significantly reduced knee pain
    compared to placebo.

    Another study done at the Fundacion Jimenez Diaz in Madrid
    found glucosamine sulphate to be more effective than the
    over-the-counter painkiller acetaminophen on joint pain.

    The Madrid trial compared a daily dose of 1500mg of
    glucosamine sulphate and 3000 mg of the OTC drug to a
    placebo in 318 patients.

    After 24 weeks, the superior efficacy of the glucosamine
    returned better results.

    In both trials there were no differences among groups in
    safety.

    The new findings on glucosamine and chondroitin sulphate
    come as welcome news to knee pain sufferers because of the
    withdrawal of Cox-2 inhibitor drugs last year.

    For additional information, including links to other news
    stories and websites, visit http://www.kneepain.us and
    http://www.myjointpain.us/jointpainglucosamine.htm

    George McKenzie is a freelance writer and CEO of Mastermind
    Learning Systems http://www.mastermindlearning.com. He’s a
    former TV news anchor and radio talk show host.

    Share and bookmark: These icons link to social bookmarking sites where readers can share and discover new web pages.
    • OnlyWire
    • Socialize-It
    • Digg
    • del.icio.us
    • Furl
    • StumbleUpon
    • Netscape
    • YahooMyWeb
    • Reddit
    • Slashdot
    • Ma.gnolia
    • RawSugar

    Comments are closed.